However, caspase-1 and ASC were activated only at later stages of AD, suggesting that while NLRP3 is primed early in the disease, potentially through early abnormal Aβ and tau accumulation31,148, full inflammasome activation, requiring a secondary signal, occurs later during AD progression. The gene discussed is MAPT; the disease is Alzheimer disease.